BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15708051)

  • 1. Effects of sildenafil citrate on ejaculation latency, detumescence time, and refractory period: placebo-controlled, double-blind, crossover laboratory setting study.
    Ekmekçioğlu O; Inci M; Demirci D; Tatlişen A
    Urology; 2005 Feb; 65(2):347-52. PubMed ID: 15708051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of three phosphodiesterase type 5 inhibitors on ejaculation latency time in lifelong premature ejaculators: a double-blind laboratory setting study.
    Gökçe A; Halis F; Demirtas A; Ekmekcioglu O
    BJU Int; 2011 Apr; 107(8):1274-7. PubMed ID: 21929518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial.
    Parker JD; Bart BA; Webb DJ; Koren MJ; Siegel RL; Wang H; Malhotra B; Jen F; Glue P
    Crit Care Med; 2007 Aug; 35(8):1863-8. PubMed ID: 17522570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chronic sildenafil treatment on penile endothelial function: a randomized, double-blind, placebo controlled study.
    Vardi Y; Appel B; Ofer Y; Greunwald I; Dayan L; Jacob G
    J Urol; 2009 Dec; 182(6):2850-5. PubMed ID: 19837434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sildenafil on middle-aged sexually active males with no erectile complaints: a randomized placebo-controlled double-blind study.
    Gruenwald I; Leiba R; Vardi Y
    Eur Urol; 2009 Apr; 55(4):969-76. PubMed ID: 18486308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sildenafil on nocturnal penile tumescence and rigidity in normal men: randomized, placebo-controlled, crossover study.
    Rochira V; Granata AR; Balestrieri A; Madeo B; Carani C
    J Androl; 2002; 23(4):566-71. PubMed ID: 12065465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation.
    Abdel-Hamid IA; El Naggar EA; El Gilany AH
    Int J Impot Res; 2001 Feb; 13(1):41-5. PubMed ID: 11313839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sildenafil inhibits beta-adrenergic-stimulated cardiac contractility in humans.
    Borlaug BA; Melenovsky V; Marhin T; Fitzgerald P; Kass DA
    Circulation; 2005 Oct; 112(17):2642-9. PubMed ID: 16246964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of phosphodiesterase type 5 inhibitors on penile rigidity variables during a period with no sexual stimulation: a laboratory setting double-blind study.
    Gökçe A; Demirtas A; Halis F; Ekmekcioglu O
    BJU Int; 2011 Jan; 107(2):264-7. PubMed ID: 20438562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sildenafil improves sleep-related erections in hypogonadal men: evidence from a randomized, placebo-controlled, crossover study of a synergic role for both testosterone and sildenafil on penile erections.
    Rochira V; Balestrieri A; Madeo B; Granata AR; Carani C
    J Androl; 2006; 27(2):165-75. PubMed ID: 16278367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo controlled crossover studies.
    McMahon CG; Touma K
    J Urol; 1999 Jun; 161(6):1826-30. PubMed ID: 10332446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of acute in vivo sildenafil citrate and in vitro 8-bromo-cGMP treatments on semen parameters and sperm function.
    du Plessis SS; de Jongh PS; Franken DR
    Fertil Steril; 2004 Apr; 81(4):1026-33. PubMed ID: 15066459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation.
    McMahon CG; Stuckey BG; Andersen M; Purvis K; Koppiker N; Haughie S; Boolell M
    J Sex Med; 2005 May; 2(3):368-75. PubMed ID: 16422868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erectile response to vardenafil in men with a history of nonresponse to sildenafil: a time-from-dosing descriptive analysis.
    Hatzichristou DG; Aliotta P; Auerbach S; Barkin J; Lording D; Murdock M; Wilkins HJ; McBride TA; Colopy MW; Carson CC;
    Clin Ther; 2005 Sep; 27(9):1452-61. PubMed ID: 16291418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension.
    Singh TP; Rohit M; Grover A; Malhotra S; Vijayvergiya R
    Am Heart J; 2006 Apr; 151(4):851.e1-5. PubMed ID: 16569546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro measurement of ejaculation latency time (ELT) and the effects of vardenafil on ELT on lifelong premature ejaculators: placebo-controlled, double-blind, cross-over laboratory setting.
    Gökçe A; Demirtas A; Halis F; Ekmekcioglu O
    Int Urol Nephrol; 2010 Dec; 42(4):881-7. PubMed ID: 20174968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sildenafil (Viagra) administration on seminal parameters and post-ejaculatory refractory time in normal males.
    Aversa A; Mazzilli F; Rossi T; Delfino M; Isidori AM; Fabbri A
    Hum Reprod; 2000 Jan; 15(1):131-4. PubMed ID: 10611201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PSD502 improves ejaculatory latency, control and sexual satisfaction when applied topically 5 min before intercourse in men with premature ejaculation: results of a phase III, multicentre, double-blind, placebo-controlled study.
    Dinsmore WW; Wyllie MG
    BJU Int; 2009 Apr; 103(7):940-9. PubMed ID: 19245438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of erectile dysfunction with sildenafil citrate in renal allograft recipients: a randomized, double-blind, placebo-controlled, crossover trial.
    Sharma RK; Prasad N; Gupta A; Kapoor R
    Am J Kidney Dis; 2006 Jul; 48(1):128-33. PubMed ID: 16797395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit: two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers.
    Houghton LA; Atkinson W; Whorwell PJ; Morris J; Murdoch RD; Cooper SM; Webber DM; Walls CM
    Clin Ther; 2006 Apr; 28(4):569-81. PubMed ID: 16750468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.